No Data
No Data
Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Report: Featuring Abeome, ABL Bio, Agenus, Akeso Biopharma, AnaptysBio, EpimAb Biotherapeutics, Immutep, Incyte and Y-Biologics
AnaptysBio(ANAB.US) Director Sells US$45,162 in Common Stock
$AnaptysBio(ANAB.US)$ Director RENTON HOLLINGS sold 1,950 shares of common stock on Jun 18, 2024 at an average price of $23.16 for a total value of $45,162.Source: Announcement What is statement of ch
AnaptysBio(ANAB.US) Officer Sells US$35,580 in Common Stock
$AnaptysBio(ANAB.US)$ Officer MULROY DENNIS sold 1,500 shares of common stock on May 22, 2024 at an average price of $23.72 for a total value of $35,580.Source: Announcement What is statement of chang
Truist Financial Maintains AnaptysBio(ANAB.US) With Hold Rating
Truist Financial analyst Joon Lee maintains $AnaptysBio(ANAB.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 22.4% over the pa
Truist Financial Sticks to Its Hold Rating for AnaptysBio (ANAB)
Industry Analysts Just Made A Captivating Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
AnaptysBio, Inc. (NASDAQ:ANAB) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The revenue forecast for this year has experien
No Data